AGP Agromep Sa

CardioComm Solutions, Inc. (TSX VENTURE:EKG) (the "Company") today provided an
update regarding the legal action that was commenced by Anglo German Progressive
I Limited ("AGP"), represented by Mr. Dirk Hagge, in July 2009 against the
Company, Dr. Anatoly Langer (the Company's Chairman and interim CEO) and Etienne
Grima (the Company's Secretary and Chief Financial Officer) in the Supreme Court
of British Columbia. AGP is a shareholder of the Company. The Company notes that
during the period of January 2008 to February 2009 Mr. Hagge served as a voting
member of the Company's Board of Directors and as a member of the audit and
finance committee. 


The Company continues to defend itself against AGP's claims vigorously. As
significant discrepancies exist in the facts surrounding the action alleged by
AGP, the request for a petition review was rejected by the court and the action
is been converted to a full legal action. The Company welcomes the opportunity
to provide oral evidence to the court. The Company has also commenced a
counterclaim against AGP for breach of contract for AGP's failure to fulfill its
funding obligations under an October 2007 subscription agreement to advance
funds to the Company. In this counterclaim, the Company seeks an order of
specific performance against AGP requiring it to complete the full amount of its
outstanding subscription ($350,000) or, in the alternative, damages for breach
of contract. 


"Since this action has commenced it has been our firm belief that it is without
merit, and we will continue to defend AGP's claims vigorously," said Dr. Anatoly
Langer. "We also intend to pursue our counterclaim against AGP, and we expect to
be fully vindicated when all is said and done." 


Dr. Langer and Mr. Grima are defending the claims against them with similar
vigor and expect to be successful in doing so. 


The Company also announced the resignation of Mr. Michael Paquin from the board
of directors, effective immediately. "We thank Mr. Paquin for his past year of
service to the Company during this important transitional year and are thankful
for his contribution as a director," said Dr. Langer. "We look forward to
working with him on new endeavors in the future." 


About CardioComm Solutions, Inc. 

CardioComm's patented and proprietary technology is used in products for the
recording, viewing, analyzing and storing of electrocardiograms (EKGs), for
diagnosis and management of cardiac patients. The Company's products are sold
worldwide through a combination of its external distribution network and its
North American based sales team. CardioComm has achieved its technical goals of
improved access and communication through the development of a real-time EKG
viewer. CardioComm is the first company to provide a real-time means of viewing
EKGs over a network (LAN, WAN or Internet). This tool enables EKGs to be viewed
and controlled live, by physicians, over a global virtual healthcare network.
This technology is marketed as Global EKG Management System (GEMS(TM)) and
GlobalCardio(TM). CardioComm's software products have been cleared for sale in
the United States by the U.S. Food and Drug Administration. The Company has
earned the latest ISO 13485 certification. 


On behalf of the Board of Directors of CardioComm Solutions, Inc. 

Dr. Anatoly Langer, Chairman

Grafico Azioni Agromep Sa (TSXV:AGP)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Agromep Sa (TSXV:AGP)
Storico
Da Giu 2023 a Giu 2024